Neurona Therapeutics publishes new study on human stem cell-derived…

Neurona Therapeutics is delighted to announce today’s publication of new peer-reviewed study in Neuron, a Cell Press journal, titled, “Human stem cell-derived GABAergic interneuron development reveals early emergence of subtype diversity and gradual electrochemical maturation”. “In this preclinical study, our team undertook systematic long-term molecular and functional characterization of human interneurons derived from pluripotent stem cells,” said Marina Bershteyn, Director of Discovery Research at Neurona Therapeutics and the study’s lead author. “By precisely specifying high-fidelity MGE interneurons synchronized at a post-mitotic migratory developmental stage before cell administration, we achieved unprecedented, durable control over the fate and function of the xenografted human interneurons.” Link to press release in comments section.